Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.
Authors
Gordon, M S; Margolin, K; Talpaz, M; Sledge, G W, Jr; Holmgren, E; Benjamin, R; Stalter, S; Shak, S; Adelman, D
Abstract
We investigated the safety and pharmacokinetics of a recombinant human monoclonal antibody to vascular endothelial growth factor (rhuMAb VEGF) in patients with cancer.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Vol 19, Issue 3, p843